32152
帕瑞昔布
VETRANAL®, analytical standard
别名:
N-[[[4-（5-甲基-3-苯基-4-异恶唑基）苯基]磺酰基]丙酰胺, N-{[4-（5-甲基-3-苯基异恶唑-4-基）苯基]磺酰基}丙酰胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C19H18N2O4S
化学文摘社编号:
分子量:
370.42
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
8640266
Gene Information
human ... PTGS2(5743)
InChI
1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22)
SMILES string
CCC(=O)NS(=O)(=O)c1ccc(cc1)-c2c(C)onc2-c3ccccc3
InChI key
TZRHLKRLEZJVIJ-UHFFFAOYSA-N
grade
analytical standard
product line
VETRANAL®
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
application(s)
forensics and toxicology
pharmaceutical (small molecule)
veterinary
format
neat
Quality Level
Application
有关合适的仪器技术的更多信息，请参阅产品的分析证书。想要获得更多支持，请联系技术服务部。
Other Notes
在我们的NMR在线平台ChemisTwin®上可以找到本品对应的数字化标准物质。您可使用ChemisTwin®上的数字等效品鉴定您的样品并进行定量分析（使用数字化外标）。可查看该物质的NMR谱图，只需点击几次鼠标，就能进行在线样品比对。欢迎点击了解更多，开启免费试用之旅。
Legal Information
VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Warning
hcodes
Hazard Classifications
Repr. 2 - STOT RE 2
存储类别
11 - Combustible Solids
wgk
WGK 3
Ippokratis Pountos et al.
Journal of cellular and molecular medicine, 15(3), 525-534 (2010-01-15)
The non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for analgesia but may inhibit bone formation. We investigated whether the reported NSAID effect on bone is related to inhibition of bone marrow mesenchymal stem cell (MSC) proliferation and osteogenic and chondrogenic
Yi Tian et al.
Journal of orthopaedic surgery and research, 15(1), 41-41 (2020-02-08)
Total knee arthroplasty (TKA) is usually associated with moderate to severe postoperative pain. Peripheral nerve block (PNB) and local infiltration analgesia (LIA) are two major methods for postoperative analgesia. Femoral nerve block (FNB) leads to residual posterior knee pain; thus
Lin-Yong Li et al.
Biology open, 6(3), 311-316 (2016-11-30)
Glioblastoma (GBM) is one of the most lethal brain cancers worldwide, and there is an urgent need for development of novel therapeutic approaches. Parecoxib is a well-known cyclooxygenase-2 (COX-2) inhibitor, and had already been developed for postoperative analgesia with high
Stephan A Schug et al.
Journal of pain research, 10, 2451-2459 (2017-10-27)
Nonselective, nonsteroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase-2 (COX-2) inhibitors are associated with safety issues including cardiovascular, renal, and gastrointestinal (GI) events. To examine the safety of parecoxib, a COX-2 inhibitor, for the management of postoperative pain. Pooled analysis of
Nicholas S Kirkby et al.
Hypertension (Dallas, Tex. : 1979), 71(2), 297-305 (2018-01-04)
Cyclooxygenase-2 (COX-2) is an inducible enzyme expressed in inflammation and cancer targeted by nonsteroidal anti-inflammatory drugs. COX-2 is also expressed constitutively in discreet locations where its inhibition drives gastrointestinal and cardiovascular/renal side effects. Constitutive COX-2 expression in the kidney regulates
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持